Prevalence of Covid-19 in Children Admitted to Paediatric Emergency Departments During the Pandemic Period in France

Study Overview
=================
Brief Summary
-----------------
Arriving in December 2019, Coronavirus COVID-19 infection is causing a global pandemic with high morbidity and mortality among adults and especially seniors. The child appears little or no affected by this infection. It is estimated that the child could be asymptomatic or pauci-symptomatic carrier and thus be vector of the disease. For this reason, measures have been taken to close schools and contain populations in a large number of countries, including France. However, there are no data on the prevalence of COVID-19 in children.

Official Title
-----------------
Prevalence of Covid-19 in Children Admitted to Paediatric Emergency Departments During the Pandemic Period in France

Conditions
-----------------
Coronavirus, COVID, Infection Viral

Intervention / Treatment
-----------------
* Diagnostic Test: nasopharyngeal swab


Participation Criteria
=================
Eligibility Criteria
-----------------
Inclusion Criteria: 1st Line Consultation in Pediatric Emergencies All reasons for consultation during working hours Informed and written consent of a parent holder (only 1 authorized companion) and a child of understanding age Exclusion Criteria: Refusal of participation by parents/child of decision age No membership of a social security scheme (beneficiary or entitled) No understanding of French

Ages Eligible for Study
-----------------
Maximum Age: 18 Years

Sexes Eligible for Study
-----------------
All

Accepts Healthy Volunteers
-----------------
No

Study Plan
=================
How is the study designed?
-----------------

Arms and Interventions

| Participant Group/Arm | Intervention/Treatment |
| --- | --- |
| Child suspected of infection with COVID-19.<br>Child included with positive included | Diagnostic Test: nasopharyngeal swab<br>* Data collection and nasopharyngeal swab<br>|

What is the study measuring?
-----------------
Primary Outcome Measures

| Outcome Measure | Measure Description | Time Frame |
| --- | --- | --- |
| Prevalence of positivity of COVID-19 virus measured by rt-PCR |  | At 28 days | 

Secondary Outcome Measures

| Outcome Measure | Measure Description | Time Frame |
| --- | --- | --- |
| Prevalence of positivity of COVID-19 virus measured by rt-PCR in the following subpopulations of emergency patients | children admitted to pediatric emergencies for respiratory signs Children hospitalized as a result of travelling to pediatric emergency departments for respiratory signs Respiratory asymptomatic children admitted to pediatric emergencies | at the end an average 28 days | 
| Respiratory signs of children tested within 28 day |  | through study completion, an average 28 days | 
| Percentage of children hospitalized tested within 28 day |  | through study completion, an average 28 days | 
| Contact frequency | the degree of relationship with these contacts and the time spent in contact with them within 24 hours before emergency | At inclusion | 
| Prevalence of positivity of other respiratory viruses measured by rt-PCR |  | at 28 days | 

 Terms related to the study
=================
Keywords Provided by Centre Hospitalier Valida
-----------------
pandemia, pediatric emergencies